Rare
lephants
Screener
Toggle theme
CRISPR Therapeutics AG
CRSP
·
Healthcare, Drug Manufacturers - General
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding
Share-Based Metrics
›
EPS
Compare
←
5Y
10Y
MAX
→
EPS
Chart
Table
EPS
Cyclically Adjusted EPS
Fiscal Year
EPS
Cyclically Adjusted EPS
FY2023
$-1.94
$-2.35
FY2024
$-4.34
$-3.05
FY2025
$-6.47
$-3.03
Download CSV
